FI751633A - - Google Patents

Info

Publication number
FI751633A
FI751633A FI751633A FI751633A FI751633A FI 751633 A FI751633 A FI 751633A FI 751633 A FI751633 A FI 751633A FI 751633 A FI751633 A FI 751633A FI 751633 A FI751633 A FI 751633A
Authority
FI
Finland
Application number
FI751633A
Other languages
Finnish (fi)
Inventor
Samuel Wilkinson
Sergio Henrique Ferreira
Roderich John Flower
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB24660/74A external-priority patent/GB1516642A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI751633A publication Critical patent/FI751633A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/46—Sulfates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI751633A 1974-06-04 1975-06-03 FI751633A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB24660/74A GB1516642A (en) 1974-06-04 1974-06-04 Biological reagent
GB5398674 1974-12-13

Publications (1)

Publication Number Publication Date
FI751633A true FI751633A (de) 1975-12-05

Family

ID=26257224

Family Applications (1)

Application Number Title Priority Date Filing Date
FI751633A FI751633A (de) 1974-06-04 1975-06-03

Country Status (12)

Country Link
US (1) US4110432A (de)
JP (1) JPS519714A (de)
AU (1) AU8180175A (de)
CH (1) CH614221A5 (de)
DE (1) DE2524637A1 (de)
DK (1) DK248775A (de)
ES (1) ES438163A1 (de)
FI (1) FI751633A (de)
FR (1) FR2273554A1 (de)
IL (1) IL47412A0 (de)
NL (1) NL7506560A (de)
SE (1) SE7506313L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188622C (nl) * 1981-12-15 1992-08-17 Cordis Europ Werkwijze ter verbetering van de bloedcompatibiliteit van een materiaaloppervlak door bekleding daarvan met een heparine of heparine-analoga en een eiwit houdende film, alsmede voorwerp, omvattende een oppervlak met verbeterde bloedcompatibiliteit verkregen onder toepassing van een op het oppervlak aangebrachte heparine of heparine-analoga en een eiwit houdende film.
US4678671A (en) * 1981-12-15 1987-07-07 Cordis Europa N.V. Conjugates of anticoagulant and protein
US4749570A (en) * 1981-12-31 1988-06-07 The Governors Of The University Of Alberta Targeting conjugates of albumin and therapeutic agents
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
EP0172962A1 (de) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandine
EP0436664B1 (de) * 1988-09-30 1994-11-09 Neorx Corporation Spaltbare linker zur reduzierung der akkumulierung von immunokonjugaten in nicht-zielorganen
US5171563A (en) * 1988-09-30 1992-12-15 Neorx Corporation Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
US6007817A (en) 1988-10-11 1999-12-28 University Of Southern California Vasopermeability enhancing immunoconjugates
DK0540670T3 (da) * 1990-07-26 1996-04-29 Monsanto Co Fremgangsmåde til fremstilling af tværbundne polyaminer
US8333996B2 (en) * 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
JP5189763B2 (ja) * 2003-04-11 2013-04-24 エテックス コーポレーション 骨誘導性骨材料
KR101218454B1 (ko) * 2004-04-15 2013-01-04 에텍스 코포레이션 세팅 지연 칼슘 포스페이트 페이스트
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3690834A (en) * 1971-01-11 1972-09-12 Syva Co Ligand determination with spin labeled compounds by receptor displacement
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies

Also Published As

Publication number Publication date
FR2273554A1 (fr) 1976-01-02
IL47412A0 (en) 1975-08-31
DK248775A (da) 1975-12-05
CH614221A5 (de) 1979-11-15
SE7506313L (sv) 1975-12-05
AU8180175A (en) 1976-12-09
ES438163A1 (es) 1977-05-16
FR2273554B1 (de) 1978-07-28
NL7506560A (nl) 1975-12-08
US4110432A (en) 1978-08-29
DE2524637A1 (de) 1976-01-02
JPS519714A (de) 1976-01-26

Similar Documents

Publication Publication Date Title
FR2273554B1 (de)
FR2264357A1 (de)
FR2261110B1 (de)
AR199810A1 (de)
CH532175A4 (de)
CH1666774A4 (de)
CH574074A5 (de)
CH573995A5 (de)
CH575806A5 (de)
CH575986A5 (de)
CH576222A5 (de)
CH576666B5 (de)
CH573074A5 (de)
CH571990A5 (de)
CH568428B5 (de)
CH575187A5 (de)
CH567956A5 (de)
CH567395A5 (de)
CH566121A5 (de)
CH564999A5 (de)
CH577679A5 (de)
CH577763A5 (de)
BG20660A1 (de)
CH578204B5 (de)
CH578659A5 (de)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THE WELLCOME FOUNDATION LTD